Mumbai: Sanofi Consumer Healthcare India Limited (“SCHIL”) (BSE: 544250, NSE: SANOFICONR) today announced its successful listing on BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE). The milestone was marked with the ringing of the opening bell at BSE by Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, signifying the listing of the company’s Equity Shares.
Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited Commenting on this joyous occasion, he said, “India’s consumer healthcare market, has vast potential. SCHIL getting listed on BSE and NSE, marks a critical milestone for us; one that is further expected to strengthen our position and drive sustainable growth within the Indian market. By evaluating our business needs, capitalizing on emerging consumer trends in the healthcare space and encouraging a culture of digital innovations, we seek to address unmet consumer needs. For this, we aim to enhance our customer experience with our products.
Further, we remain committed to our mission, which is to make self-care as simple as it should be and empower our consumers to take control of their health. I am confident that our organisation’s consumer-first approach will drive our ambition to build the best ‘Fast Moving Consumer Healthcare’ (FMCH) organisation in and for the world.”
SCHIL has emerged as a distinct legal entity following its demerger from Sanofi India Limited. This demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on 1st June 2024. In alignment with Sanofi’s global strategy, SCHIL is now operating independently, with a dedicated focus on the Consumer Healthcare sector. SCHIL is committed to maintaining high standards of ethics, marketing practices, and business operations.
About Sanofi Consumer Healthcare India Limited (SCHIL): With an agile business model and strong brands, SCHIL is one of the leading players in India’s consumer healthcare market. Leveraging its global experience in consumer healthcare, Sanofi Consumer Healthcare India Limited (SCHIL) aims to enhance customer wellbeing through its portfolio of products which encompasses Allergy, Digestive Wellness, Pain Care, and Multivitamins and Herbal/Traditional Dietary Supplements. SCHIL’s key brands include Allegra®, DePURA®, Avil®, and Combiflam®. They are dedicated to building a healthier future for their customers by empowering people to take control of their health, through self-care and by addressing their everyday health concerns.
+ There are no comments
Add yours